FDA shall probably grant an EUA to Mesoblast for COVID-19 ARDS because it’s the best available therapy, proven to high degree of statistical relevance, and there is now a growing concern about fully vaccinated people getting serious ARDS from the new variants.There were 37 confirmed cases in UK of Lambda as of 4th August, 2021. Also authorities are worried about the B.1.621 variant which was first detected in Colombia but is a lineage of the Kappa variant of the coronavirus, where unfortunately vaccines don’t seem to work.Here is a serious development on this:
newhttps://www.reuters.com/world/europe/seven-die-after-outbreak-colombian-variant-covid-19-belgian-nursing-home-2021-08-06/ variants
banter and General Discussion, page-2834
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |